|
Home
Web Presence
Why "TRIFID" Medical?
| |
News and Milestones
 | August 5, 2004
Alveoli Medical LLC awarded
National Institutes of Health (NIH) Small Business Innovation Research
(SBIR) Phase I grant. |
| June 7, 2004
Alveoli Medical LLC is formed to
develop state-of-the-art respiratory care devices. |
| October 10, 2003
Sharn Anesthesia introduces the ELH
Ergonomic Laryngoscope Handle. |
| October 3, 2003
National Science Foundation (NSF) selects Robert Virag, TRIFID Medical Group
LLC, as commercial reviewer for the 2003 Small Business Innovation Research
(SBIR) grant awards for Phase II research applications. |
| September 11, 2003
Centerbridge, Inc. appoints Robert Virag as a member of the Advisory Board.
Centerbridge, Inc. is a medical device technology start-up currently
developing a complete Modular Personal Health Infrastructure capability to
greatly enhance health, fitness and lifestyle management for the individuals
it serves. Products under development include Personal Data
Collection Hub in the home and on the road, Personal Medical Devices
for seamless, transparent easy objective data collection, and Personal
Health Services web sites that allow comparison with normative data,
motivational reinforcement, email, voice messages, education, reminders,
rewards and links to affiliated sites for additional personal information. |
| December 5, 2002
ASTM F29 Anesthesia and Respiratory Standards committee appoints Robert
Virag as Chairman of the ASTM F29.19 subcommittee for Patient Warming
Equipment Standards. |
| October 4, 2002
National Science Foundation (NSF) selects Robert Virag, TRIFID Medical Group
LLC, as commercial reviewer for the 2002 Small Business Innovation Research
(SBIR) grant awards for Phase II research applications. |
| May 5, 2002
ASTM F29 Anesthesia and Respiratory Standards committee appoints board
member Robert Virag, TRIFID Medical Group LLC, as ASTM F29 Treasurer. |
| February 12, 2002
TRIFID Medical Group LLC enrolls as an FDA
CDRH United States Agent for Medical Devices. New FDA regulations
(21 CFR 807.40) state that foreign medical device manufacturers may
designate only one United States agent who is either a resident of the
United States or maintains a place of business in the United States. The
foreign establishment may designate its United States agent as its Official
Correspondent to:
- assist FDA in communications with the foreign establishment,
- respond to questions concerning the foreign establishment's products
that are imported or offered for import into the United States,
- assist FDA in scheduling inspections of the foreign establishment,
and
- if FDA is unable to contact the foreign establishment directly or
expeditiously, FDA may provide information or documents to the United
States agent, and such an action shall be considered to be equivalent to
providing the same information or documents to the foreign
establishment.
|
| December 5, 2001
ASTM F29 Anesthesia and Respiratory Standards committee elects Robert Virag,
TRIFID Medical Group LLC, member-at-large of the Executive Committee |
| May 1, 2001
TRIFID Medical Group establishes Internet Presence |
| May 1, 2001
Why "TRIFID" Medical?? |
|
